Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now full pipeline small index

Respiratory Distress Syndrome: full-pipeline trial registry

4 of 9 indexed Respiratory Distress Syndrome trials are currently recruiting.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 4 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Respiratory Distress Syndrome: 9 US clinical trials tracked, 4 recruiting.

Respiratory Distress Syndrome is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Windtree Therapeutics, running 1 of these trials.

Enrollment posture brief

Registry condition respiratory-distress-syndrome

OPEN 4 | RECR 44% | LATE 3 | EARLY 2 | RANK #1916 | SPON 1

Nearest open-share peer: Acute Ischemic Stroke (44% recruiting · 27 trials)

Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Respiratory Distress Syn (th…44%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Respiratory Distress Syndrome

Respiratory Distress Syndrome lists 4 open slots (44% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Respiratory Distress Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Respiratory Distress Syndrome is recruiting below its size-band peers.

    4 of 9 indexed trials (44.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Respiratory Distress Syndrome trials is spread across many organizations.

    Windtree Therapeutics accounts for 1 of 9 trials (11.1%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Respiratory Distress Syndrome enrolment sits around 80 participants.

    Median target enrolment is 80 among the 9 trials that report a genuine target (sentinel values excluded). 5 of those (55.6%) plan for fewer than 100 participants.

  4. Respiratory Distress Syndrome splits between interventional and observational designs.

    6 interventional and 3 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21Phase 32Phase 41

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 3 2
Phase 4 1

Named interventions

Most-linked intervention names on Respiratory Distress Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Respiratory Distress Group Other
1 trials
Respiratory epithelial cell brushing Diagnostic test
1 trials
nCPAP Drug
1 trials
Lucinactant delivered via investigational delivery device Drug
1 trials
vasoactive intestinal peptide Drug
1 trials
surfactant (poractant alfa;Curosurf) Drug
1 trials
budesonide (Pulmicort nebulizing suspension). Drug
1 trials
Transcutaneous Biopac Electrical Stimulator Device
1 trials

US sites by state

Facility locations filed on Respiratory Distress Syndrome trials. A trial with sites in several states counts in each.

New York 5 trials
Texas 3 trials
Ohio 3 trials
California 3 trials
Rhode Island 2 trials
Pennsylvania 2 trials
North Carolina 2 trials
Mississippi 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Respiratory Distress Syndrome page

9 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 4 Respiratory Distress Syndrome trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Windtree Therapeutics sponsors the most Respiratory Distress Syndrome trials on record, review their full trial history before evaluating a specific study. See Windtree Therapeutics's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Respiratory Distress Syndrome condition card totals 9 registered trials; most-linked intervention Respiratory Distress Group; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.